Syngene Adopts Symyx Technologies, Inc.'s DiscoveryGate Content Platform

SANTA CLARA, Calif.--(BUSINESS WIRE)--Symyx Technologies, Inc. (Nasdaq:SMMX) is pleased to announce that Syngene International Limited (a Biocon Company) has licensed Symyx’s online DiscoveryGate content platform including CrossFire Beilstein, Patent Chemistry Database, Symyx Available Chemicals Directory (Symyx ACD) and a selection of Symyx Synthetic Methodology Databases. Syngene is a Bangalore-based custom research company offering multidisciplinary drug discovery services in synthetic chemistry and molecular biology.